Machine Learning and AI in Pharmaceutical Analysis: A New Era of Precision and Efficiency

Area of Science:

• Pharmaceutical analysis
• Computational chemistry
• Drug development

Background:

• Artificial Intelligence (AI), Machine Learning (ML), and Deep Learning (DL) are revolutionizing pharmaceutical analysis.
• AI techniques like neural networks, SVM, and RF are crucial for processing complex pharmaceutical datasets.
• Big data analytics increasingly relies on AI for informed decision-making in drug development.

Purpose of the Study:

• To review current applications of AI and ML in pharmaceutical analysis.
• To identify challenges and future prospects of AI in the pharmaceutical sector.
• To highlight AI's role in accelerating drug discovery, formulation, and quality control.

Main Methods:

• Review of AI and ML applications in spectroscopic and chromatographic data interpretation (e.g., HPLC, mass spectrometry, UV, IR, NMR, Raman).
• Analysis of AI-driven predictive modeling for drug behavior, stability, and release profiles.
• Examination of AI in real-time quality monitoring and Good Manufacturing Practices (GMP) compliance.

Main Results:

• AI significantly accelerates drug discovery and development by identifying candidates and predicting interactions.
• AI models, particularly DL (CNNs, RNNs), improve the accuracy of compound identification from complex spectral data.
• AI enhances formulation design, predicts drug release, and supports stability studies for better product development.

Conclusions:

• AI integration, especially DL, is transforming pharmaceutical analysis, improving efficiency and accuracy.
• AI facilitates real-time quality monitoring, ensuring GMP and regulatory compliance.
• Future trends indicate broader AI implementation in personalized medicine and adaptive clinical trials.